Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components

v3.8.0.1
Balance Sheet Components
 3 Months Ended
Mar. 31, 2018
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Balance Sheet Components

NOTE 7 — BALANCE SHEET COMPONENTS

Accrued liabilities were comprised of the following (in thousands):

 

 

 

March 31,

 

 

December 31,

 

 

 

2018

 

 

2017

 

Accrued liabilities:

 

 

 

 

 

 

 

 

General and administrative

 

$

670

 

 

$

374

 

Clinical costs

 

 

734

 

 

 

702

 

Non-clinical research

 

 

868

 

 

 

435

 

Payroll related

 

 

491

 

 

 

1,149

 

Other accrued expenses

 

 

37

 

 

 

30

 

Total accrued liabilities

 

$

2,800

 

 

$

2,690

 

Deferred revenue was comprised of the following:

 

 

 

March 31,

 

 

December 31,

 

 

 

2018

 

 

2017

 

Deferred revenue:

 

 

 

 

 

 

 

 

Grant agreements

 

$

1,421

 

 

$

1,673

 

Research and development agreements

 

 

4,929

 

 

 

1,092

 

Total deferred revenue

 

$

6,350

 

 

$

2,765